The Curing Coma Campaign: Framing Initial Scientific Challenges-Proceedings of the First Curing Coma Campaign Scientific Advisory Council Meeting
Open Access
- 1 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neurocritical Care
- Vol. 33 (1), 1-12
- https://doi.org/10.1007/s12028-020-01028-9
Abstract
Coma and disordered consciousness are common manifestations of acute neurological conditions and are among the most pervasive and challenging aspects of treatment in neurocritical care. Gaps exist in patient assessment, outcome prognostication, and treatment directed specifically at improving consciousness and cognitive recovery. In 2019, the Neurocritical Care Society (NCS) launched the Curing Coma Campaign in order to address the "grand challenge" of improving the management of patients with coma and decreased consciousness. One of the first steps was to bring together a Scientific Advisory Council including coma scientists, neurointensivists, neurorehabilitationists, and implementation experts in order to address the current scientific landscape and begin to develop a framework on how to move forward. This manuscript describes the proceedings of the first Curing Coma Campaign Scientific Advisory Council meeting which occurred in conjunction with the NCS Annual Meeting in October 2019 in Vancouver. Specifically, three major pillars were identified which should be considered: endotyping of coma and disorders of consciousness, biomarkers, and proof-of-concept clinical trials. Each is summarized with regard to current approach, benefits to the patient, family, and clinicians, and next steps. Integration of these three pillars will be essential to the success of the Curing Coma Campaign as will expanding the "curing coma community" to ensure broad participation of clinicians, scientists, and patient advocates with the goal of identifying and implementing treatments to fundamentally improve the outcome of patients.Keywords
This publication has 68 references indexed in Scilit:
- Therapy Development for Diffuse Axonal InjuryJournal of Neurotrauma, 2013
- Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain InjuryThe New England Journal of Medicine, 2012
- National Institute of Neurological Disorders and Stroke Common Data Element Project – approach and methodsClinical Trials, 2012
- Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort studyCMAJ : Canadian Medical Association Journal, 2011
- Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndromeBMC Medicine, 2010
- Recovery of consciousness after brain injury: a mesocircuit hypothesisTrends in Neurosciences, 2010
- Default network connectivity reflects the level of consciousness in non-communicative brain-damaged patientsBrain, 2009
- Effects of Methylphenidate on Cerebral Glucose Metabolism in Patients With Impaired Consciousness After Acquired Brain InjuryClinical Neuropharmacology, 2009
- Incidence of Clinically Significant Responses to Zolpidem Among Patients with Disorders of ConsciousnessAmerican Journal of Physical Medicine & Rehabilitation, 2009
- Validation of a new coma scale: The FOUR scoreAnnals of Neurology, 2005